Inhibition of Notch signaling rescues cardiovascular development in Kabuki Syndrome.
Ontology highlight
ABSTRACT: Kabuki Syndrome patients have a spectrum of congenital disorders, including congenital heart defects, the primary determinant of mortality. Seventy percent of Kabuki Syndrome patients have mutations in the histone methyl-transferase KMT2D. However, the underlying mechanisms that drive these congenital disorders are unknown. Here, we generated and characterized zebrafish kmt2d null mutants that recapitulate the cardinal phenotypic features of Kabuki Syndrome, including microcephaly, palate defects, abnormal ear development, and cardiac defects. The cardiac phenotype consists of a previously unknown vasculogenesis defect that affects endocardium patterning and, consequently, heart ventricle lumen formation. Additionally, zebrafish kmt2d null mutants have angiogenesis defects depicted by abno
SUBMITTER: Serrano MLA
PROVIDER: S-EPMC6743796 | biostudies-literature | 2019 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA